Ann Marie Mauer to Drug Administration Schedule
This is a "connection" page, showing publications Ann Marie Mauer has written about Drug Administration Schedule.
Connection Strength
0.191
-
Phase II trial of oxaliplatin, leucovorin and fluorouracil in patients with advanced carcinoma of the esophagus. Ann Oncol. 2005 Aug; 16(8):1320-5.
Score: 0.057
-
Phase I study of docetaxel with concomitant thoracic radiation therapy. J Clin Oncol. 1998 Jan; 16(1):159-64.
Score: 0.034
-
A phase 2 study of cetuximab in combination with docetaxel in chemotherapy-refractory/resistant patients with advanced nonsmall cell lung cancer. Cancer. 2009 Apr 15; 115(8):1713-22.
Score: 0.019
-
Eicosanoid modulation in advanced lung cancer: cyclooxygenase-2 expression is a positive predictive factor for celecoxib + chemotherapy--Cancer and Leukemia Group B Trial 30203. J Clin Oncol. 2008 Feb 20; 26(6):848-55.
Score: 0.017
-
Phase II trial of gefitinib 250 mg daily in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck. Clin Cancer Res. 2005 Dec 01; 11(23):8418-24.
Score: 0.015
-
A phase II study of bryostatin-1 and paclitaxel in patients with advanced non-small cell lung cancer. Lung Cancer. 2003 Feb; 39(2):191-6.
Score: 0.012
-
Anaphylactoid reactions to Escherichia coli and Erwinia asparaginase in children with leukemia and lymphoma. Cancer. 1982 Apr 01; 49(7):1378-83.
Score: 0.012
-
Correlation of cell kinetic and clinical response to chemotherapy in disseminated neuroblastoma. Cancer Res. 1977 Oct; 37(10):3766-70.
Score: 0.008
-
Paclitaxel/carboplatin plus ifosfamide in non-small cell lung cancer. Semin Oncol. 1997 Aug; 24(4 Suppl 12):S12-67-S12-69.
Score: 0.008
-
Evidence for recruitment and synchronization in leukemia and solid tumors. Cancer Treat Rep. 1976 Dec; 60(12):1841-4.
Score: 0.008